Literature DB >> 35981857

Comparison of Effects of Capromorelin and Mirtazapine on Appetite in New Zealand White Rabbits (Oryctolagus cuniculus).

Janna Mh Draper1, Daniel J Savson1, Elizabeth S Lavin1, Erica R Feldman1, Bhupinder Singh1, Manuel Martin-Flores2, Erin K Daugherity1.   

Abstract

Inappetence is a welfare concern in rabbits (Oryctolagus cuniculus), as it can lead to potentially fatal gastrointestinal stasis. In other species, inappetence is commonly treated with appetite stimulants; however, few published studies have evaluated the efficacy of appetite stimulants in rabbits. We performed 2 studies to evaluate the effects of capromorelin and mirtazapine on appetite in New Zealand White (NZW) rabbits. In the first study, healthy rabbits ( n = 9) were evaluated using a randomized crossover design and 9 treatments: capromorelin 4 mg/kg oral (PO) once a day (SID), capromorelin 8 mg/kg PO SID, saline control PO SID, capromorelin 4 mg/kg PO twice a day (BID), capromorelin 8 mg/kg PO BID, saline control PO BID, mirtazapine 0.5 mg/kg transdermal (TD) SID, mirtazapine 1 mg/kg TD SID, and saline control TD SID for 3 d with a 1-wk washout period between treatments. Treatment efficacy was assessed by measuring daily feed intake and fecal output and by weighing rabbits twice a week. Overall, feed intake and fecal output were higher for all treatments as compared with controls, except for fecal output in the capromorelin 4 mg/kg and 8 mg/kg PO SID groups. Feed intake and fecal output were significantly higher with mirtazapine as compared with capromorelin. Body weight and erythema/petechia of the pinnae were greater in the mirtazapine 1 mg/kg TD SID group than in the control group. A second study evaluated rabbits that had undergone surgery (castration, n = 7) and then received one of 3 treatments: capromorelin 8 mg/kg PO BID, mirtazapine 1 mg/kg TD SID, or saline PO BID for 3 d postoperatively. Feed intake and fecal output in the postoperative mirtazapine group were not significantly different from those of the capromorelin and control groups. Due to its superior efficacy as compared with capromorelin in healthy NZW rabbits, we recommend considering mirtazapine as a treatment for inappetence in NZW rabbits.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35981857      PMCID: PMC9536823          DOI: 10.30802/AALAS-JAALAS-22-000003

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.706


  14 in total

1.  Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.

Authors:  Manuel Martin-Flores; Bhupinder Singh; Courtney A Walsh; Elizabeth P Brooks; Lacic Taylor; Lisa M Mitchell
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-03-01       Impact factor: 1.232

2.  Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult Beagle dogs.

Authors:  B Zollers; L Rhodes; R G Smith
Journal:  J Vet Pharmacol Ther       Date:  2016-09-05       Impact factor: 1.786

3.  Effects of Cisapride, Buprenorphine, and Their Combination on Gastrointestinal Transit in New Zealand White Rabbits.

Authors:  Erica R Feldman; Bhupinder Singh; Noah G Mishkin; Erica R Lachenauer; Manuel Martin-Flores; Erin K Daugherity
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-02-25       Impact factor: 1.232

4.  The Social Nature of European Rabbits (Oryctolagus cuniculus).

Authors:  Louis DiVincenti; Angelika N Rehrig
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-11       Impact factor: 1.232

Review 5.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

6.  Evaluation of the safety in dogs of long-term, daily oral administration of capromorelin, a novel drug for stimulation of appetite.

Authors:  B Zollers; M Huebner; G Armintrout; L C Rausch-Derra; L Rhodes
Journal:  J Vet Pharmacol Ther       Date:  2016-09-25       Impact factor: 1.786

7.  Single and multiple dose pharmacokinetics of a novel mirtazapine transdermal ointment in cats.

Authors:  William Buhles; Jessica M Quimby; Daizie Labelle; Valentine S Williams
Journal:  J Vet Pharmacol Ther       Date:  2018-07-13       Impact factor: 1.786

8.  A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite.

Authors:  B Zollers; J A Wofford; E Heinen; M Huebner; L Rhodes
Journal:  J Vet Intern Med       Date:  2016-11       Impact factor: 3.333

Review 9.  Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs.

Authors:  Linda Rhodes; Bill Zollers; Jessica A Wofford; Ernst Heinen
Journal:  Vet Med Sci       Date:  2017-11-06

Review 10.  Rabbit gastroenterology.

Authors:  Brigitte Reusch
Journal:  Vet Clin North Am Exot Anim Pract       Date:  2005-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.